Why the study?
Does the in vitro bleeding test (IVBT) using Thrombostat 4000 improve sensitivity for detecting von Willebrand's disease compared to the Simplate bleeding time?
Does the in vitro bleeding test (IVBT) using Thrombostat 4000 improve sensitivity for detecting von Willebrand's disease compared to the Simplate bleeding time?
The in vitro bleeding test using Thrombostat 4000 demonstrates superior sensitivity to the standard Simplate bleeding time for screening von Willebrand's disease.
No takes yet. Share an insight, caveat, or question.
May support IVBT for vWD screening; observational data leave open replacement of bleeding time pending validation.
Weippert-Kretschmer et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: